Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia
Year: 2009
Type: article
Source: Critical Care Medicine
Authors: Masaru Nagato, Kohji Okamoto, Yukio Abe, Aiichiro Higure, Koji Yamaguchi
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2081073452
